A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 599-605

  Freedman, Gary M ^a   Fowble, Barbara L ^a   Hanlon, Alexandra L ^a   Myint, Maung A ^a   Hoffman, John P ^a   Sigurdson, Elin R ^a   Eisenberg, Burton L ^a   Goldstein, Lori J ^a   Fein, Douglas A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Margins; Mastectomy; Postmastectomy radiation; Young women

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; THORAX WALL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE;

EID: 0031802024     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00103-5     Document Type: Article

References (47)

1. Nattinger A.B., Gottlieb M.S., Veum J., Yahnke D., Goodwin J.S. Geographic variation in the use of breast-conserving treatment for breast cancer. N. Engl. J. Med. 326:1992;1102-1107.
2. Arriagada R., Rutqvist L.E., Mattsson A., Kramar A., Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J. Clin. Oncol. 13:1995;2689-2878.
3. Effects of radiotherapy and surgery in early breast cancer. N. Engl. J. Med. 333:1995;1444-1455.
4. Host H., Brennhoud I.O., Loeb M. Post-operative radiotherapy in breast cancer Long term results from the Oslo study . Int. J. Radiat. Oncol. Biol. Phys. 12:1986;727-732.
5. Rutqvist L.E., Pettersson D., Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer long-term follow-up of a randomized clinical trial . Radiother. Oncol. 26:1993;104-110.
6. Ahlborn T.N., Gump F.E., Bodian C., Habif D.V., Kister S. Tumor to fascia margin as a factor in local recurrence after modified radical mastectomy. Surg. Gynecol. Obstet. 166:1988;523-526.
7. Mentzer S.J., Osteen R.T., Wilson R.E. Local recurrence and the deep resection margin in carcinoma of the breast. Surg. Gynecol. Obstet. 16:1986;513-517.
8. Baker R.R., Montague A.C., Childs J.N. A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer. Ann. Surg. 189:1979;553-559.
9. Lee Y.N. Breast carcinoma pattern of recurrence and metastasis after mastectomy . Am. J. Clin. Oncol. 7:1984;443-449.
10. Maddox W.A., Carpenter J.T., Laws H.L., Soong S.J., Cloud G., Urist M.M., Balch C.M. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann. Surg. 198:1983;207-212.
11. Rosenman J., Bernard S., Kober C., Leland W., Varia M., Newsome J. Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (1970-1982). Cancer. 57:1986;1421-1425.
12. Fowble B., Gray R., Gilchrist K., Goodman R.L., Taylor S., Tormey D.C. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J. Clin. Oncol. 6:1988;1107-1117.
13. Griem K.L., Henderson I.C., Gelman R., Ascoli D., Silver B., Recht A., Goodman R.L., Hellman S., Harris J.R. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J. Clin. Oncol. 5:1987;1546-1555.
14. Gröhn P., Heinonen E., Klefström P., Tarkkanen J. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer. 54:1984;670-674.
15. Klefström P., Gröhn P., Heinonen E., Holsti L., Holsti P. Adjuvant postoperative radiotherapy, chemotherapy and immunotherapy in stage III breast cancer. Cancer. 60:1987;936-942.
16. Marks L.B., Halperin E.C., Prosnitz L.R., Ross M., Vredenburgh J.J., Rosner G.L., Peters W. The Cancer and Leukemia Group B. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥10 positive axillary lymph nodes. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;1021-1026.
17. Olson J.E., Neuberg D., Pandya K.J., Richter M.P., Solin L.J., Gilchrist K.W., Tormey D.C., Veeder M., Falkson G. The role of radiotherapy in the management of operable locally advanced breast carcinoma. Cancer. 79:1997;1138-1149.
18. Pisansky T.M., Ingle J.N., Schaid D.J., Hass A.C., Krook J.E., Donohue J.H., Witzig T.E., Wold L.E. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact on clinical, histopathologic and flow cytometric factors. Cancer. 72:1993;1247-1260.
19. Ragaz J., Jackson S., Le N., Plenderleith I.H., Spinelli J., Wilson K., Knowling M., Olivotto I., Coldman A. Can adjuvant locoregional therapy reduce systemic recurrences in stage I-II breast cancer patients? Recurrence analysis of the British Columbia Randomized Trial. Proc. Am. Soc. Clin. Oncol. 15:1996;121.
20. Spangenberg J.P., Nel C.J., Anderson J.D., Doman M.J. A prospective study of the treatment of stage III breast cancer. S. Afr. J. Surg. 24:1986;57-60.
21. Stefanik D., Goldberg R., Byrne P., Smith F., Ueno W., Smith L., Harter K., Bachenheimer L., Beiser C., Dritschilo A. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 3:1985;660-665.
22. Sykes H.F., Sim D.A., Wong C.J., Cassady J.R., Salmon S.E. Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy evaluation of the role of postmastectomy radiation . Int. J. Radiat. Oncol. Biol. Phys. 16:1989;641-647.
23. Vélez-García E., Carpenter J.T. Jr, Moore M., Vogel C.L., Marcial V., Ketcham A., Singh K.P., Bass D., Bartolucci A.A., Smalley R. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes a South-Eastern Cancer Study Group (SEG) trial . Eur. J. Cancer. 28A:1992;1833-1837.
24. Allen H., Brooks R., Jones S.E., Chase E., Heusinkveld R.S., Giordano G.F., Ketchel S.J., Jackson R.A., Davis S., Moon T.E., Salmon S.E. Adjuvant treatment for stage II (node positive) breast cancer with adriamycin-cyclophosphamide (AC) ± radiotherapy (XRT). Salmon S.E., Jones S.E. Adjuvant therapy for cancer III. 1981;453-562 Grune & Stratton, New York.
25. Rao A.R., Murthy A.K., Hendrickson F.R., Rossof A., Bonomi P., Shorey W. Analysis of risk factors for loco-regional failure in stage II (T1N1M0 & T2N1M0) breast carcinoma treated with mastectomy and adjunctive chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 11:1985;151-152.
26. Armitage P. Statistical methods in medical research. 1973;135-136 John Wiley & Sons, New York.
27. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
28. Lawless J.E. Statistical models and methods for lifetime data. 1982;John Wiley & Sons, New York.
29. SAS technical report P-179, additional SAS/STAT procedures, release 6.03. 1988;49-89 NCL SAS Institute Inc, Cary, NC.
30. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 16:1988;1141-1154.
31. Kalbfleish J.D., Prentice R.L. The statistical analysis of failure time data. 1980;Wiley, New York.
32. Fowble B. Postmastectomy radiation Then and now . Oncology. 11:1997;213-239.
33. Chen T.Y., Emrich L.J., Driscoll D.L. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;833-837.
34. Looser K.G., Shah J.P., Strong E.W. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1:1978;107-111.
35. Anscher M.S., Prosnitz L.R. Multivariate analysis of factors predicting local relapse after radical prostatectomy - possible indications for postoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;941-947.
36. Epstein J.I., Pizov G., Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 71:1993;3582-3593.
37. Adam I.J., Mohamdee M.O., Martin I.G., Scott N., Finan P.J., Johnston D., Dixon M.F., Quirke P. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 344:1994;707-711.
38. Freedman G.M., Fowble B.L., Hanlon A.L., Fein D.A., Hoffman J.P., Sigurdson E.R., Goldstein L.J. Postmastectomy radiation and adjuvant systemic therapy. Breast J. 3:1997;337-344.
39. Chung M., Chang H.R., Bland K.I., Wanebo H.J. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 77:1996;97-103.
40. Hankey B.F., Miller B., Curtis R., Kosary C. Trends in breast cancer in younger women in contrast to older women. Monogr. Natl. Cancer Inst. 16:1994;7-14.
41. Winchester D.P., Osteen R.T., Menck H.R. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 78:1996;1838-1843.
42. Donegan W.L., Perez-Mesa C.M., Watson F.R. A biostatistical study of locally recurrent breast carcinoma. Surg. Gynecol. Obstet. 122:1966;529-540.
43. Fletcher G.H., McNeese M.D., Oswald M.J. Long-range results for breast cancer patients treated by radical mastectomy and postoperative radiation without adjuvant chemotherapy An update . Int. J. Radiat. Oncol. Biol. Phys. 17:1989;11-14.
44. Lewis D., Rienhoff W.F. Jr. A study of the results of operations for the cure of cancer of the breast, performed at Johns Hopkins Hospital from 1889 to 1931. Ann. Surg. 95:1932;336-400.
45. Matthews R.H., McNeese M.D., Montague E.D., Oswald M.J. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;659-663.
46. Crowe J.P. Jr, Gordon N.H., Antunez A.R., Shenk R.R., Hubay C.A., Shuck J.M. Local-regional breast cancer recurrence following mastectomy. Arch. Surg. 126:1991;429-432.
47. Goldhirsch A., Gelber R.D., Price K.N., Castiglione M., Coates A.S., Rudenstam C-M, Collins J., Lindtner J., Hacking A., Marini G., Byrne M., Cortés-Funes H., Schnürch G., Brunner K.W., Tattersall M.H.N., Forbes J., Senn H-J. Effect of systemic adjuvant treatment on first sites of breast cancer relapse. Lancet. 343:1994;377-381.